Molecular imaging of experimental atherosclerosis using anti-malondialdehyde-modified low-density lipoprotein humanised antibody fragment targeted nanoparticles

28 August 2022 (08:15 - 09:00)
Organised by:
Congress Presentation Part of: Targeting lipids and lipid-related pathways in cardiovascular disease Vascular Diseases ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by